Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15194633.
- Also identified by PMC identifier 1774121.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New corticotropin releasing factor (CRF) antagonists in irritable bowel disease (IBS) warrant testing, and CRF1 receptors may be a promising target for the treatment of IBS.
Medical subject headings
- Gastrointestinal Agents
- Irritable Bowel Syndrome
- Receptors, Corticotropin-Releasing Hormone